Heparin Sodium In Sodium Chloride Injection, Solution
NDC Package 51662-1578-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Heparin Sodium In Sodium Chloride injection is heparin sodium is indicated for:Prophylaxis and treatment of venous thromboembolism and pulmonary embolism; Atrial fibrillation with embolization; Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and cardiac surgery; Prophylaxis and treatment of peripheral arterial embolism; Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures. This formulation utilizes a injection, solution delivery system. Marketed by Hf Acquisition Co Llc, Dba Healthfirst, this product is identified by NDC 51662-1578 and is authorized under FDA application NDA017029.

Identification & Billing

NDC Package Code
51662-1578-1
Package Description
250 mL in 1 BAG
Product Code
51662-1578
11-Digit Billing Format
51662157801
RxNorm Crosswalk
  • RxCUI: 1658717 - heparin sodium, porcine 25,000 UNT in 250 ML Injection
  • RxCUI: 1658717 - 250 ML heparin sodium, porcine 100 UNT/ML Injection
  • RxCUI: 1658717 - heparin sodium, porcine 25,000 UNT per 250 ML Injection

Clinical Specifications

Proprietary Name
Heparin Sodium In Sodium Chloride
Non-Proprietary Name
Heparin Sodium In Sodium Chloride
Substance Name
Heparin Sodium
Dosage Form
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
HEPARIN SODIUM 10000 [USP'U]/100mL
Pharmacologic Class
Usage Information
Heparin sodium is indicated for:Prophylaxis and treatment of venous thromboembolism and pulmonary embolism; Atrial fibrillation with embolization; Treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and cardiac surgery; Prophylaxis and treatment of peripheral arterial embolism; Anticoagulant use in blood transfusions, extracorporeal circulation, and dialysis procedures.

Regulatory & Marketing

Labeler Name
Hf Acquisition Co Llc, Dba Healthfirst
Product Type
Human Prescription Drug
FDA Application #
NDA017029
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-15-2021
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51662-1578-1 identifies a specific commercial package of 250 ml in 1 bag of Heparin Sodium In Sodium Chloride, a human prescription drug labeled by Hf Acquisition Co Llc, Dba Healthfirst. This injection, solution is formulated for intravenous use and contains heparin sodium as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hf Acquisition Co Llc, Dba Healthfirst on July 15, 2021. The current certification is valid through December 31, 2026.

How is this Hf Acquisition Co Llc, Dba Healthfirst product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51662157801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51662-1578-1
11-Digit CMS (5-4-2)
51662-1578-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.